(Q37895373)

English

Coronary no reflow

scientific article published on 21 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

Coronary no reflow (English)

1 reference

Europe PubMed Central

24 August 2017

author name string

Bryan G Schwartz

1

1 reference

Europe PubMed Central

24 August 2017

Robert A Kloner

2

1 reference

Europe PubMed Central

24 August 2017

publication date

21 June 2011

1 reference

Europe PubMed Central

24 August 2017

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

24 August 2017

52

1 reference

Europe PubMed Central

24 August 2017

4

1 reference

Europe PubMed Central

24 August 2017

873-882

1 reference

Europe PubMed Central

24 August 2017

Blood Supply of the Myocardium after Temporary Coronary Occlusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Endothelial glycocalyx and coronary vascular permeability: the fringe benefit

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Evaluation of dynamic changes in microvascular flow during ischemia-reperfusion by myocardial contrast echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

"Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia. Role of oxygen radical-induced no-reflow phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Molecular and cellular mechanisms of myocardial stunning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

A radical view on the contractile machinery in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Xanthine oxidase as a source of free radical damage in myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Coronary microembolization: from bedside to bench and back to bedside

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Distal embolization during primary angioplasty: histopathologic features and predictability.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Thrombus aspiration during primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Measurement of regional myocardial blood flow with multiple colored microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Evaluating the 'no reflow' phenomenon with myocardial contrast echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Assessment of no-reflow regions using cardiac MRI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Carvedilol preserves endothelial junctions and reduces myocardial no-reflow after acute myocardial infarction and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Comparison of the effects of nicorandil versus verapamil on the incidence of slow flow/no reflow during rotational atherectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection device.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Left ventricular contractile function after distal protection in primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Mapping preconditioning's signaling pathways: an engineering approach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Cardioprotection: nitric oxide, protein kinases, and mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Postconditioning the human heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Long-term benefit of postconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Intracoronary streptokinase after primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.06.009

7 January 2021

Identifiers

10.1016/J.YJMCC.2011.06.009

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37895373&oldid=2114162910"